These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 6768077)

  • 1. Direct evidence for involvement of dopaminergic inhibition and cholinergic activation in yawning.
    Yamada K; Furukawa T
    Psychopharmacology (Berl); 1980 Jan; 67(1):39-43. PubMed ID: 6768077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Age-related modification of dopaminergic-cholinergic neuronal interaction in rats].
    Kishimoto O
    Yakubutsu Seishin Kodo; 1988 Dec; 8(4):443-51. PubMed ID: 3250156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modification of apomorphine-, physostigmine- and pilocarpine-induced yawning after long-term treatment with neuroleptic or cholinergic agents.
    Ushijima I; Noda Y; Mizuki Y; Yamada M
    Arch Int Pharmacodyn Ther; 1984 Oct; 271(2):180-8. PubMed ID: 6150689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Muscarinic and nicotinic effects on yawning and tongue protruding in the rat.
    Ushijima I; Yamada K; Inoue T; Tokunaga T; Furukawa T; Noda Y
    Pharmacol Biochem Behav; 1984 Aug; 21(2):297-300. PubMed ID: 6541344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of yawning behavior induced by apomorphine, physostigmine and pilocarpine.
    Ushijima I; Mizuki Y; Imaizumi J; Yamada M; Noda Y; Yamada K; Furukawa T
    Arch Int Pharmacodyn Ther; 1985 Feb; 273(2):196-201. PubMed ID: 4004417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Yawning induced by apomorphine, physostigmine or pilocarpine is potentiated by dihydropyridine calcium channel blockers.
    Bourson A; Moser PC
    Psychopharmacology (Berl); 1990; 100(2):168-72. PubMed ID: 1689500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioral effects of dilazep on cholinergic, dopaminergic, and purinergic systems in the rat.
    Ushijima I; Mizuki Y; Ukita T; Kaneyuki H; Inano S; Yamada M
    Pharmacol Biochem Behav; 1992 Nov; 43(3):673-6. PubMed ID: 1360158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of bifemelane on central dopaminergic and cholinergic systems in rats].
    Ushijima I; Tsutsumi C; Hara T; Soeda K; Kishimoto O; Kaneyuki H; Mizuki Y; Yamada M
    Yakubutsu Seishin Kodo; 1988 Dec; 8(4):463-70. PubMed ID: 2907957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multifocal sites of action involved in dopaminergic-cholinergic neuronal interactions in yawning.
    Ushijima I; Mizuki Y; Yamada M
    Psychopharmacology (Berl); 1988; 95(1):34-7. PubMed ID: 3133698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modifications on dopaminergic and cholinergic systems induced by the water tank technique: analysis through yawning behavior.
    Neumann BG; Troncone LR; Braz S; Tufik S
    Arch Int Pharmacodyn Ther; 1990; 308():32-8. PubMed ID: 2099135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of cholinergic and dopaminergic influences on yawning behavior.
    Holmgren B; Urbá-Holmgren R
    Acta Neurobiol Exp (Wars); 1980; 40(3):633-42. PubMed ID: 6969021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apomorphine produced more yawning in Sprague-Dawley rats than in F344 rats: a pharmacological study.
    Tang AH; Himes CS
    Eur J Pharmacol; 1995 Sep; 284(1-2):13-8. PubMed ID: 8549616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopaminergic and cholinergic interaction in cataleptic responses in mice.
    Ushijima I; Kawano M; Kaneyuki H; Suetsugi M; Usami K; Hirano H; Mizuki Y; Yamada M
    Pharmacol Biochem Behav; 1997 Sep; 58(1):103-8. PubMed ID: 9264077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions of drugs acting on central dopamine receptors and cholinoceptors on yawning responses in the rat induced by apomorphine, bromocriptine or physostigmine.
    Zarrindast MR; Poursoltan M
    Br J Pharmacol; 1989 Apr; 96(4):843-8. PubMed ID: 2663110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Partial agonistic effects of OPC-14597, a potential antipsychotic agent, on yawning behavior in rats.
    Fujikawa M; Nagashima M; Inoue T; Yamada K; Furukawa T
    Pharmacol Biochem Behav; 1996 Apr; 53(4):903-9. PubMed ID: 8801596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Yawning elicited by systemic and intrastriatal injection of piribedil and apomorphine in the rat.
    Dourish CT; Cooper SJ; Philips SR
    Psychopharmacology (Berl); 1985; 86(1-2):175-81. PubMed ID: 2991964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of age on behavioral responses to dopamine agonists in the rat.
    Ushijima I; Mizuki Y; Soeda K; Kishimoto O; Hara T; Yamada M
    Eur J Pharmacol; 1987 Jun; 138(1):101-6. PubMed ID: 2887433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potentiation by serotonergic inhibition of yawning induced by dopamine receptor agonists in rats.
    Matsumoto S; Yamada K; Nagashima M; Matsuo N; Shirakawa K; Furukawa T
    Pharmacol Biochem Behav; 1989 Mar; 32(3):815-8. PubMed ID: 2525786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute or chronic effects of cannabinoids on spontaneous or pharmacologically induced yawning in rats.
    Nakamura-Palacios EM; Amodeo Bueno OF; Takahashi RN; Tufik S
    Pharmacol Biochem Behav; 2002 Dec; 74(1):205-12. PubMed ID: 12376169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Septohippocampal cholinergic pathway and penile erections induced by dopaminergic and cholinergic stimulants.
    Maeda N; Matsuoka N; Yamaguchi I
    Brain Res; 1990 Dec; 537(1-2):163-8. PubMed ID: 1982238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.